Cvrx Inc (CVRX) Stock Price, Quote & News

Company Profile

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was...

Industry: Medical Devices

Sector: Healthcare

Phone: 763 416 2840

Fax: 763 416 2841

Website: www.cvrx.com

Address:

9201 West Broadway Avenue, Suite 650, Minneapolis, United States

commoncentsinvestor Jun. 19 at 1:07 AM

$CVRX drmunirjanmohamed's profile picture drmunirjanmohamed 1d 🎉 Exciting Milestone Alert! 🎉 We are thrilled to announce the successful completion of our 10th Barostim implant at Mercy General Hospital. This procedure represents a novel treatment of heart failure, offering new hope and improved quality of life for our patients. https://www.instagram.com/p/DLAtOIIvHMl/

1 · Reply

MITornado Jun. 18 at 1:43 PM

$CVRX how many more implants per month/per rep would be needed to get to break even?

2 · Reply

MedDevice Jun. 17 at 9:10 PM

$CVRX listening to the comparisons by management of CardioMEMS, i was curious on the timeline to a NCD from Medicare. Roughly 10.5 years. CardioMEMS trial (guide HF) missed its endpoint as well, but had over 5x the number of patients studied.

1 · Reply

1111tu Jun. 16 at 7:05 PM

$CVRX CMS news may arrive the week of July 7. News arrived in 2023 on 7/11 and 2024 7/10.

0 · Reply

commoncentsinvestor Jun. 16 at 12:57 PM

$CVRX Andover, KS – KANSAS MEDICAL CENTER has announced the hospital’s first successful implantation of Barostim™ Baroreflex Activation Therapy, the world’s first FDA–approved heart failure (HF) device to use neuromodulation – the power of the brain and nervous system – to improve the symptoms of patients with systolic heart failure. This advanced, award–winning therapy was designed to treat HF patients who have had little to no success with other proven treatment options. https://ksmedcenter.com/featured/successful-implant-of-barostim-baroreflex-activation-therapy-for-the-treatment-of-heart-failure-symptoms/

2 · Reply

wlvsbyote Jun. 16 at 12:23 PM

$CVRX 👀 been awhile...almost ready maybe🐾☑️

0 · Reply

bballz Jun. 13 at 3:04 PM

$CVRX do they know insurance denials affect their hard work of selling implants?

0 · Reply

commoncentsinvestor Jun. 12 at 9:08 PM

$CVRX Alfred 4 June, 2025 I have the cvrx barostim implant. Last June I could barely walk 20’ and by August I was doing my 6 miniite walk no problem. Now 3,000 steps a day is routine. My refraction rate went from low 20’s to 55. This is the greatest advancement in heart failure treatment ever. It is a life changer.

1 · Reply

RocketThief Jun. 12 at 4:49 PM

$CVRX low volume dip on what looks like a better cash pile than when I last checked on this, swing starter

0 · Reply

commoncentsinvestor Jun. 12 at 4:47 PM

$CVRX Congratulations to Dr. Robert Mendes, Dr. Micah Pherson, Dr. Elizabeth Volz, Erica Mountjoy, NP, and Meaghan Tordella, PA, and the @UNCHealthRex Hospital team on their 25th #Barostim implant! Thank you for advancing #heartfailure care by providing innovative therapy options to your patients.https://x.com/CVRx_Barostim/status/1932152205798170705

0 · Reply

CVRx to Present at the William Blair 45th Annual Growth Stock Conference

May 10, 2025, 3:51 PM EDT - 6 weeks ago

CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript

Apr 24, 2025, 4:30 PM EDT - 2 months ago

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025

Apr 9, 2025, 8:45 AM EDT - 2 months ago

CVRx Inc: Overreaction Creates Buying Opportunity

Apr 8, 2025, 8:35 AM EDT - 2 months ago

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

GBX RPM

Apr 7, 2025, 4:05 PM EDT - 2 months ago

CVRx Reports Preliminary First Quarter 2025 Financial Results

Feb 12, 2025, 2:45 PM EST - 4 months ago

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

Feb 4, 2025, 11:00 PM EST - 5 months ago

CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript

Feb 4, 2025, 4:05 PM EST - 5 months ago

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Jan 21, 2025, 4:30 PM EST - 5 months ago

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

Dec 23, 2024, 4:30 PM EST - 6 months ago

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 20, 2024, 4:30 PM EST - 7 months ago

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 6, 2024, 9:04 PM EST - 8 months ago

CVRx: Impressive Top-Line Growth Seems Priced In

Oct 29, 2024, 10:38 PM EDT - 8 months ago

CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript

Oct 18, 2024, 2:08 PM EDT - 8 months ago

CVRx announces new CPT® Category I codes for Barostim

Oct 15, 2024, 4:30 PM EDT - 9 months ago

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

Sep 3, 2024, 8:30 AM EDT - 10 months ago

CVRx Announces Appointment of Two New Board Members

Aug 19, 2024, 4:00 PM EDT - 11 months ago

CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Aug 19, 2024, 11:00 AM EDT - 11 months ago

The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join

Aug 18, 2024, 11:00 AM EDT - 11 months ago

The Schall Law Firm Is Seeking CVRx Inc Shareholders To Join Fraud Investigation

Aug 17, 2024, 11:00 AM EDT - 11 months ago

CVRx Inc Shareholders Can Join Fraud Investigation With The Schall Law Firm

Aug 16, 2024, 11:00 AM EDT - 11 months ago

CVRx Inc Investors Encouraged To Participate In Fraud Inquiry With The Schall Law Firm

Aug 15, 2024, 11:00 AM EDT - 11 months ago

CVRx Inc Shareholders Urged To Participate In Fraud Inquiry With The Schall Law Firm

Aug 14, 2024, 10:30 PM EDT - 11 months ago

CVRx Inc Shareholders Invited To Join Fraud Inquiry With The Schall Law Firm

Aug 14, 2024, 12:30 AM EDT - 11 months ago

CVRx Inc Investors May Participate In Fraud Investigation With The Schall Law Firm

Aug 13, 2024, 2:00 AM EDT - 11 months ago

CVRx Inc Investors Urged To Join The Fraud Investigation With The Schall Law Firm

Aug 9, 2024, 8:30 PM EDT - 11 months ago

CVRx Inc Investors Encouraged to Participate in Fraud Investigation With The Schall Law Firm

Aug 8, 2024, 4:00 PM EDT - 11 months ago

CVRx Inc Investors Can Join Fraud Investigation With The Schall Law Firm

Aug 7, 2024, 4:15 PM EDT - 11 months ago

CVRx Inc Investors Are Eligible To Join Fraud Investigation With The Schall Law Firm

Aug 6, 2024, 3:30 PM EDT - 11 months ago

CVRx Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

Aug 5, 2024, 11:00 AM EDT - 11 months ago

CVRX Investors Have Opportunity to Join CVRx, Inc. Fraud Investigation with the Schall Law Firm

Aug 2, 2024, 8:00 AM EDT - 11 months ago

CVRx Announces Increased Inpatient Payment for Barostim Procedure

Jul 31, 2024, 4:27 PM EDT - 11 months ago

CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference

commoncentsinvestor Jun. 19 at 1:07 AM

1 · Reply

MITornado Jun. 18 at 1:43 PM

$CVRX how many more implants per month/per rep would be needed to get to break even?

2 · Reply

MedDevice Jun. 17 at 9:10 PM

1 · Reply

1111tu Jun. 16 at 7:05 PM

$CVRX CMS news may arrive the week of July 7. News arrived in 2023 on 7/11 and 2024 7/10.

0 · Reply

commoncentsinvestor Jun. 16 at 12:57 PM

2 · Reply

wlvsbyote Jun. 16 at 12:23 PM

$CVRX 👀 been awhile...almost ready maybe🐾☑️

0 · Reply

bballz Jun. 13 at 3:04 PM

$CVRX do they know insurance denials affect their hard work of selling implants?

0 · Reply

commoncentsinvestor Jun. 12 at 9:08 PM

1 · Reply

RocketThief Jun. 12 at 4:49 PM

$CVRX low volume dip on what looks like a better cash pile than when I last checked on this, swing starter

0 · Reply

commoncentsinvestor Jun. 12 at 4:47 PM

0 · Reply

commoncentsinvestor Jun. 12 at 4:44 PM

$CVRX Congratulations to Dr. Robert Mendes, Dr. Micah Pherson, Dr. Elizabeth Volz, Erica Mountjoy, NP, and Meaghan Tordella, PA, and the @UNCHealthRex Hospital team on their 25th #Barostim implant! Thank you for advancing #heartfailure care by providing innovative therapy options to your patients. https://x.com/CVRx_Barostim/status/1932152205798170705

0 · Reply

MedDevice Jun. 12 at 3:18 PM

$CVRX William Blair conference offered no additional details on the new trial discussed on earnings call. What drives this stock higher other than that? Acquisition? January 2026 permanent code is only a small positive, not a lifeline for a single product company. Interesting they specifically mentioned an uptick in inpatient care also.

1 · Reply

MITornado Jun. 10 at 2:22 PM

$CVRX

0 · Reply

MITornado Jun. 10 at 11:19 AM

$CVRX looks like they are starting to figure out the approach and reimbursement. Post on Linkedin showing 25th implant at one of their hospitals. Others will follow.

0 · Reply

bballz Jun. 6 at 5:03 PM

$CVRX still doing the mickey mouse booths at meetings...they should be doing standing room only presentations instead..

0 · Reply

bballz Jun. 6 at 4:54 PM

$CVRX he wont be at cvrx next year

0 · Reply

bballz Jun. 6 at 2:24 PM

$CVRX insurance authorizations are a headwind.

1 · Reply

1111tu Jun. 6 at 3:14 AM

Tonight $CVRX posted several ISHLT 2025 physician presentations on the subject of Barostim. In one video, “Integrating Barostim into a Comprehensive HF Program” discloses that a paper written by Dr. Brian Howard MD has been accepted for publication.

1 · Reply

edvquye Jun. 5 at 4:23 PM

$CVRX tight channel for the past 7 trading days, hoping for the next move up soon

0 · Reply

commoncentsinvestor Jun. 4 at 6:43 PM

$CVRX INTERESTING, but no guarantee. Ai view of Medical device stocks: "Companies to Watch: Several companies are positioned for strong performance in 2025, based on their innovative offerings, financial strength, and market positioning: Fastest Growing (according to Financial Times): Procept BioRobotics, CVRx, RxSight, Inspire Medical Systems, electroCore, Senseonics, Biotricity, Axonics, Haytek Lentes, and HCT Solutions."

1 · Reply

MedDevice Jun. 4 at 3:30 PM

$CVRX Same song, different day. What about the new trial mentioned on the last earnings call?

1 · Reply

MITornado Jun. 3 at 10:35 PM

$CVRX

1 · Reply

Market Cap	152.27M
Revenue (ttm)	51.29M
Net Income (ttm)	-59.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-116.92%
Debt to Equity Ratio	0.71

Volume	147,100
Avg Vol	359,296
Day's Range	N/A - N/A
Shares Out	26.07M
Stochastic %K	49%
Beta	1.30
Analysts	Strong Sell
Price Target	$14.00